Medpace Holdings, Inc. (MEDP) Ownership
MEDP ownership summary
as of October 18, 2026- Institutions
- 90.7% of shares outstanding
- Insiders
- 18.77% of shares outstanding
- Shares outstanding
- 27.9M
- Float
- 22.7M shares available to trade
- Short interest
- 7.13% 1.6M shares short
- Days to cover
- 6.58 short interest down 5.3% vs prior month
- Institutions 90.74%
- Insiders 18.77%
MEDP top institutional holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | BlackRock Inc | 8.95% | 2.5M | $1.55B | +27,808 (+1.1%) | June 30, 2026 |
| 2 | T. Rowe Price Associates, Inc. | 7.42% | 2.1M | $1.28B | +1.8M (+614.9%) | June 30, 2026 |
| 3 | AQR Capital Management LLC | 4.58% | 1.3M | $791.0M | −74,902 (−5.5%) | June 30, 2026 |
| 4 | Vanguard Portfolio Management, LLC | 4.06% | 1.1M | $700.9M | +11,668 (+1.0%) | June 30, 2026 |
| 5 | Vanguard Capital Management, LLC | 3.68% | 1.0M | $635.1M | +15,749 (+1.6%) | June 30, 2026 |
| 6 | State Street Corp | 2.55% | 711K | $439.7M | +28,666 (+4.2%) | June 30, 2026 |
| 7 | Geode Capital Management, LLC | 2.55% | 710K | $439.4M | −34,641 (−4.6%) | June 30, 2026 |
| 8 | Wasatch Advisors LP | 2.28% | 637K | $393.7M | −137,336 (−17.7%) | June 30, 2026 |
| 9 | Amvescap Plc. | 2.08% | 579K | $358.2M | +1,667 (+0.3%) | June 30, 2026 |
| 10 | Baillie Gifford & Co Limited. | 1.70% | 473K | $292.7M | −29,980 (−6.0%) | June 30, 2026 |
| 11 | Arrowstreet Capital Limited Partnership | 1.54% | 429K | $265.3M | +33,243 (+8.4%) | June 30, 2026 |
| 12 | Renaissance Technologies Corp | 1.49% | 416K | $257.0M | −89,080 (−17.7%) | June 30, 2026 |
| 13 | Dimensional Fund Advisors, Inc. | 1.42% | 398K | $245.8M | +49,015 (+14.1%) | June 30, 2026 |
| 14 | Morgan Stanley - Brokerage Accounts | 1.14% | 318K | $196.4M | +29,126 (+10.1%) | June 30, 2026 |
| 15 | UBS Group AG | 1.09% | 304K | $188.0M | −36,507 (−10.7%) | June 30, 2026 |
| 16 | Bessemer Group Inc | 1.01% | 283K | $175.0M | −2,534 (−0.9%) | June 30, 2026 |
| 17 | Mawer Investment Management Ltd | 0.96% | 267K | $165.2M | −178,929 (−40.1%) | June 30, 2026 |
| 18 | TD Global Investment Solutions – TD Epoch | 0.95% | 267K | $164.9M | +125,588 (+89.1%) | June 30, 2026 |
| 19 | TD Asset Management Inc | 0.95% | 264K | $163.2M | +130,819 (+98.3%) | June 30, 2026 |
| 20 | Thrivent Financial For Lutherans | 0.92% | 256K | $158.5M | +24,849 (+10.7%) | June 30, 2026 |
Value at the latest close. Change = shares bought or sold in the latest quarterly filing (13F). In the top 20, 12 holders added 2.3M shares and 8 cut 584K.
MEDP top mutual fund and ETF holders
20 largest| # | Holder | % of shares | Shares | Value | Change | Reported |
|---|---|---|---|---|---|---|
| 1 | iShares Core S&P Mid-Cap ETF | 2.89% | 805K | $498.1M | −288 (−0.0%) | September 30, 2026 |
| 2 | Vanguard MStar Total Stk Mkt Idx Invest | 2.60% | 726K | $449.2M | −816 (−0.1%) | August 31, 2026 |
| 3 | Vanguard Small Cap Index | 1.80% | 503K | $310.9M | −23,044 (−4.4%) | September 30, 2026 |
| 4 | Invesco S&P MidCap Quality ETF | 1.18% | 329K | $203.6M | +345 (+0.1%) | September 30, 2026 |
| 5 | Vanguard Explorer Inv | 1.06% | 295K | $182.6M | +81,869 (+38.4%) | June 30, 2026 |
| 6 | Vanguard MStar Small Cap Growth Indx Inv | 1.00% | 280K | $172.9M | −22,168 (−7.3%) | September 30, 2026 |
| 7 | iShares Biotechnology ETF | 0.63% | 175K | $108.4M | −1,328 (−0.8%) | September 30, 2026 |
| 8 | FullerThaler Behavioral Sm-Cp Eq R6 | 0.62% | 173K | $107.0M | +126,495 (+271.7%) | June 30, 2026 |
| 9 | T. Rowe Price Lrg Cp Gr I | 0.61% | 170K | $105.1M | −1,024 (−0.6%) | September 30, 2026 |
| 10 | State Street® SPDR® S&P MIDCAP 400® ETF | 0.60% | 167K | $103.4M | +2,173 (+1.3%) | September 30, 2026 |
| 11 | TD Global Capital Reinvestment - I | 0.52% | 145K | $89.5M | −3,300 (−2.2%) | June 30, 2026 |
| 12 | Wasatch Core Growth | 0.49% | 137K | $84.5M | −24,748 (−15.3%) | June 30, 2026 |
| 13 | iShares S&P Mid-Cap 400 Growth ETF | 0.47% | 130K | $80.7M | −140 (−0.1%) | September 30, 2026 |
| 14 | iShares Russell Mid-Cap Growth ETF | 0.45% | 127K | $78.4M | −135 (−0.1%) | September 30, 2026 |
| 15 | State Street SPDR Port S&P 400 Md CpETF | 0.43% | 120K | $73.9M | −168 (−0.1%) | September 30, 2026 |
| 16 | Fidelity Extended Market Index | 0.39% | 110K | $68.0M | −2,195 (−2.0%) | August 31, 2026 |
| 17 | Madison Mid Cap Y | 0.38% | 105K | $65.1M | −2,081 (−1.9%) | September 30, 2026 |
| 18 | Strategic Advisers U.S. Total Stock | 0.36% | 99K | $61.3M | +2,587 (+2.7%) | August 31, 2026 |
| 19 | iShares Russell Mid-Cap ETF | 0.33% | 93K | $57.6M | +171 (+0.2%) | September 30, 2026 |
| 20 | Fidelity Mid Cap Index | 0.31% | 88K | $54.3M | +377 (+0.4%) | August 31, 2026 |
Funds report holdings monthly or quarterly; dates differ by fund.
MEDP insider transactions
latest 20| Date | Name | Transaction | Price | Shares | Value |
|---|---|---|---|---|---|
| 2026-03-17 | Jesse J Geiger | Sell | $455.30 | 31,707 | $14.4M |
| 2026-02-26 | David Taylor | Buy | $447.09 | — | — |
| 2026-01-29 | David Taylor | Buy | $593.07 | — | — |
| 2026-01-16 | David Taylor | Sell | $610.90 | — | — |
| 2026-01-15 | Gilbert Ray Cisneros, Jr. | Sell | $618.04 | — | — |
| 2025-12-03 | August J Troendle | Sell | $590.69 | 668 | $394,581 |
| 2025-12-01 | August J Troendle | Sell | $593.25 | 23,178 | $13.8M |
| 2025-11-28 | August J Troendle | Sell | $593.46 | 15,151 | $9.0M |
| 2025-11-26 | August J Troendle | Sell | $606.88 | 41,331 | $25.1M |
| 2025-11-25 | August J Troendle | Sell | $615.52 | 42,392 | $26.1M |
| 2025-11-24 | Susan E Burwig | Sell | $609.15 | 20,000 | $12.2M |
| 2025-11-24 | August J Troendle | Sell | $607.78 | 59,025 | $35.9M |
| 2025-11-21 | August J Troendle | Sell | $592.18 | 21,858 | $12.9M |
| 2025-11-21 | Kevin M Brady | Sell | $590.35 | 3,000 | $1.8M |
| 2025-11-20 | August J Troendle | Sell | $598.49 | 6,830 | $4.1M |
| 2025-11-19 | August J Troendle | Sell | $592.07 | 23,862 | $14.1M |
| 2025-11-18 | August J Troendle | Sell | $590.84 | 7,191 | $4.2M |
| 2025-11-17 | August J Troendle | Sell | $591.00 | 6,047 | $3.6M |
| 2025-11-14 | August J Troendle | Sell | $595.26 | 14,747 | $8.8M |
| 2025-11-14 | Robert O Kraft | Sell | $591.85 | 6,472 | $3.8M |
Reported trades by company officers, directors and other filers (including disclosures by members of Congress where EODHD lists them). "—" where the filing gives no share count.
MEDP shares outstanding
Year-end shares outstanding, adjusted for splits.
Who owns MEDP
Institutional investors own 90.7% of Medpace's shares and insiders 18.77%. The largest holder is BlackRock Inc with 8.95% of the shares (2.5M), as of June 30, 2026. Among the top 20 institutions, 12 added shares and 8 reduced their stake in the latest filings. Short interest is 7.13% of the float, or 6.58 days of average trading volume. The share count fell 26.9% since 2014.
Related: MEDP analyst forecast, MEDP key metrics. See the MEDP stock overview for the latest quote and news.
MEDP ownership FAQ
Who owns the most Medpace stock?
The largest shareholders of Medpace are BlackRock Inc (8.95%), T. Rowe Price Associates, Inc. (7.42%), AQR Capital Management LLC (4.58%), Vanguard Portfolio Management, LLC (4.06%), Vanguard Capital Management, LLC (3.68%).
What percentage of Medpace is owned by institutions?
Institutions hold 90.7% of Medpace's shares outstanding; insiders hold 18.77%.
Which funds own Medpace?
The largest fund holders of Medpace are iShares Core S&P Mid-Cap ETF (2.89%), Vanguard MStar Total Stk Mkt Idx Invest (2.60%), Vanguard Small Cap Index (1.80%), Invesco S&P MidCap Quality ETF (1.18%), Vanguard Explorer Inv (1.06%).
What is Medpace's short interest?
1.6M shares of Medpace were sold short, 7.13% of the float; at the average daily volume it would take 6.58 days to cover.
Are insiders buying or selling Medpace?
Of the latest 20 reported insider transactions in Medpace (since November 14, 2025), 2 were purchases and 18 were sales.
How many shares of Medpace are outstanding?
Medpace has 27.9M shares outstanding, of which 22.7M are in the public float.